^
Association details:
| Biomarker: | EGFR L860R |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Tagrisso (osimertinib) (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
MA11.01 - Development of Novel EGFR Mutant NSCLC Mouse Models and Murine Cell Lines: New Tools for NSCLC Research
Published date:
08/18/2021
Excerpt:
...multiple tumors throughout all lobes of the lung in both del19 and L860R mice. Time to tumor formation occurred within 4-12 weeks. Importantly, treatment of the mice with osimertinib resulted in tumor shrinkage and improvement in the health of mice.
